<DOC>
	<DOCNO>NCT02616172</DOCNO>
	<brief_summary>Autologous human bone marrow mononuclear fraction ( BMMF ) harvest give child bilateral moderate severe sensorineural hearing loss . The aim determine bone marrow mononuclear fraction ( BMMF ) infusion safe , feasible , improve inner ear function , audition , language development .</brief_summary>
	<brief_title>Autologous Bone Marrow Harvest Transplant Sensorineural Hearing Loss</brief_title>
	<detailed_description>Autologous human bone marrow mononuclear fraction ( BMMF ) give child bilateral moderate severe sensorineural hearing loss . Subjects come Orlando pretesting include Magnetic Resonance Imaging ( MRI ) , Auditory brainstem response ( ABR ) , blood work : Complete metabolic panel ( CMP ) , Complete blood count ( CBC ) , Hepatic Function Panel , Prothrombin ( PT ) , Partial thromboplastin time ( PTT ) , International normalize ration ( INR ) , Chest Xray , Speech Language Evaluation . After pretesting , subject undergo bone marrow harvest receive autologous bone marrow mononuclear fraction ( BMMF ) intravenously . The subject monitor 24 hour post infusion . After 24 hour , subject undergo repeat blood work chest x ray . Subjects discharge home . Subjects follow Orlando 1 month , 6 month 1 year post infusion . Follow test repeat exam perform pretesting .</detailed_description>
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<mesh_term>Hearing Loss , Sensorineural</mesh_term>
	<criteria>1 . Evidence sensorineural hearing loss , Bilaterally Moderate Profound degree Symmetrical asymmetrical configuration Sudden progressive presentation 2 . Normally shaped cochlea , determine Magnetic Resonance Imaging compute tomography ( CT ) 3 . The loss must consider : Acquired Unknown genetic test negative . ( Genetic testing require Cytomegalovirus ( CMV ) positive child due Cytomegalovirus ( CMV ) know number one cause hearing loss ) 4 . Fitted hearing aid later six month post detection loss unless recommend treating audiologist physicians 5 . Enrollment parent/child intervention program 6 . Age 2 year 6 year old time infusion 2 4 year time elapse since diagnosis hearing loss time bone marrow mononuclear fraction ( BMMF ) infusion . 7 . Ability child caregiver travel Orlando , stay least 4 day , return followup visit . 1 . Inability obtain pertinent medical record : ( pertinent physician note , speech language pathology note , laboratory finding , test result image studiesmust send research team least prior subject arrive study location preliminary screening eligibility assessment , preferably14 day schedule visit . ) 2 . Known history : Recently treat ( ear infection ) infection le 2 week infusion . Renal disease alter renal function define serum creatinine &gt; 1.5 mg/dl admission . Hepatic disease alter liver function define Alanine Transaminase ( SGPT ) &gt; 150 U/L , Total Bilirubin &gt; 1.3 mg/dL Malignancy Immunosuppression define White Blood Cell ( WBC ) &lt; 3,000 admission Human Immunodeficiency Virus ( HIV ) Hepatitis B Hepatitis C Pneumonia , chronic lung disease require oxygen 3 . Any evidence active maternal infection pregnancy 4 . Participation concurrent intervention study 5 . Mild hearing loss evidence moderate severe loss 6 . Unwillingness inability stay 4 day follow infusion ( problem arise follow infusion ) return one month , six month one year followup visit . 7 . Evidence conductive hearing loss 8 . Documented recurrent middle ear infection frequent ( &gt; 5 per year ) 9 . Otitis medium time examination 10 . Before 2 year identification hear loss time infusion 11 . After 4 year identification hear loss time infusion 12 . Diagnosis follow syndromic cause hearing loss CHARGE Waardenburg BrachioOtoRenal Pendred Alport TreacherCollins Usher Stickler Syndrome</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>